Although these results need to be further confirmed by randomized controlled trials, they may be of public health interest, as several prospective studies have identified elevated plasma concentration of copeptin as an independent risk factor for development of new-onset diabetes mellitus, decline of renal function, and cardiovascular disease [2, 3, 9–11]. Here, AVP is linked to cardiovascular disorder.